Cargando…

Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis

Liver fibrosis is a common feature of chronic liver disease. Activated hepatic stellate cells (HSCs) are the main drivers of extracellular matrix accumulation in liver fibrosis. Hence, a strategy for regulating HSC activation is crucial in treating liver fibrosis. Mesenchymal stem cells (MSCs) are m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chanbin, Kim, Minju, Han, Jinsol, Yoon, Myunghee, Jung, Youngmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615475/ https://www.ncbi.nlm.nih.gov/pubmed/34829827 http://dx.doi.org/10.3390/biomedicines9111598

Ejemplares similares

sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p
por: Kim, Jieun, et al.
Publicado: (2021)

Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model
por: Kim, Jieun, et al.
Publicado: (2023)

Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
por: Han, Jinsol, et al.
Publicado: (2022)

Pathophysiological Aspects of Alcohol Metabolism in the Liver
por: Hyun, Jeongeun, et al.
Publicado: (2021)

Deficiency of Formyl Peptide Receptor 2 Retards Hair Regeneration by Modulating the Activation of Hair Follicle Stem Cells and Dermal Papilla Cells in Mice
por: Han, Jinsol, et al.
Publicado: (2021)

Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver
por: Lee, Chanbin, et al.
Publicado: (2023)

Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease
por: Lee, Chanbin, et al.
Publicado: (2022)

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015)

Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells
por: Wang, Sihyung, et al.
Publicado: (2020)

Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling
por: Kim, Jieun, et al.
Publicado: (2017)

Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
por: Yao, Yunqi, et al.
Publicado: (2021)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
por: Zhang, Rui, et al.
Publicado: (2022)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Crosstalk between NK cells and hepatic stellate cells in liver fibrosis
por: Zhang, Yang, et al.
Publicado: (2022)

MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
por: Hyun, Jeongeun, et al.
Publicado: (2016)

Stellate cells are mesenchymal stem cells
por: Kordes, Claus, et al.
Publicado: (2014)

Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver
por: Kim, Jieun, et al.
Publicado: (2015)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Does CB-1 in hepatic stellate cells contribute to liver fibrosis?
por: Lotersztajn, Sophie, et al.
Publicado: (2022)

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
por: Yin, Xiaochun, et al.
Publicado: (2022)

MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver
por: Kim, Jieun, et al.
Publicado: (2018)

Generation of functionally competent hepatic stellate cells from human stem cells to model liver fibrosis in vitro
por: Lai, Xinyuan, et al.
Publicado: (2022)

Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation
por: Najimi, Mustapha, et al.
Publicado: (2017)

Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
por: Li, Dan, et al.
Publicado: (2015)

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
por: Zhang, Chong-Yang, et al.
Publicado: (2016)

Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis
por: Barcena-Varela, Marina, et al.
Publicado: (2019)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells
por: Arroyo, Noelia, et al.
Publicado: (2021)

The Effects of Irisin on the Interaction between Hepatic Stellate Cell and Macrophage in Liver Fibrosis
por: Do, Dinh Vinh, et al.
Publicado: (2022)

Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression
por: Wijayasiri, Pramudi, et al.
Publicado: (2022)

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
por: Ye, Bingyu, et al.
Publicado: (2023)

Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells
por: Le, Cong Thuc, et al.
Publicado: (2023)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis
por: Ogawa, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2v49g3o5aju0d7j7g2gjbpnnv